Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Evaluering af YouControl-AFib, en mHealth-applikation til personer med atrieflimren

1. september 2026 opdateret af: University of Wisconsin, Madison

Implementering af YouControl-AFib mHealth-applikationen (pilotversion) for at forbedre fysisk aktivitet hos personer med atrieflimren

This study is being done to establish the feasibility of performing a clinical trial using a mHealth application named YouControl-AFib designed to improve the cardiovascular health of persons with atrial fibrillation. The study will obtain feedback on the app design to inform future versions and will collect preliminary data to support proof-of-concept and potential effect sizes for future trial design.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

Primary Objective

  • To effectively recruit participants for a clinical trial and obtain user feedback on the mHealth app using the Mobile App Rating Scale and focus group sessions.

Secondary Objectives

  • To evaluate the impact of the YouControl-AFib mHealth app (pilot version, 3 months of use) on physical activity in persons with atrial fibrillation.
  • To obtain several additional functional and disease specific endpoints that will help establish possible effect sizes to be evaluated more formally in subsequent versions of the mHealth application.
  • To obtain user feedback on the mHealth app using the Mobile App Rating Scale and focus group sessions.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

51

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Wisconsin
      • Madison, Wisconsin, Forenede Stater, 53792
        • UW School of Medicine and Public Health

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 80 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Ability to understand and the willingness to sign a written informed consent document
  • Willing to comply with all study procedures and be available for the duration of the study
  • SmartPhone capable of pairing with a Fitbit Sense 2 and Fitbit App (Apple iOS 15 and higher or Android 10 or higher)
  • Paroxysmal or persistent atrial fibrillation verified by 12-lead electrocardiogram (ECG) or other clinical grade monitoring
  • body mass index (BMI) greater than 27

Exclusion Criteria:

  • History of permanent atrial fibrillation
  • Left ventricular ejection fraction (LVEF) less than 45 percent
  • Myocardial infarction, coronary artery bypass grafting, or valve surgery within the last 12 months
  • Moderate to severe valve disease
  • Inability to participate in a structured exercise program due to musculoskeletal disease
  • Already participating in a structured exercise program or achieving guideline directed physical activity
  • Planned surgery or procedure during the next three months that limit ability to engage in physical activity

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Personer, der bruger YouControl-A-Fib-appen

Participants will use the app for 3 months, includes 1 month phone call with Health Coach

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Average Number of Participants Recruited Per Month
Tidsramme: up to 6 months
up to 6 months
Maximum Number of Participants Recruited in a Single Month
Tidsramme: up to 6 months
up to 6 months
Mobile App Rating Scale Score
Tidsramme: 3 months

Mobile App Rating Scale contains several subscales that will each be scored on a scale of 1-5; B-functionality, C-aesthetics, and D-information. Higher scores indicate high levels of functionality, aesthetics, and information quality. The overall mean score for all sub-scales is reported here.

3 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in 6-minute Walk Distance (Compared to Baseline for Each Participant) After Using the mHealth App for 3 Months
Tidsramme: baseline, 3 months
baseline, 3 months
Weekly Step Count After Using the mHealth App for Three Months
Tidsramme: week 1, week 12
week 1, week 12
Intentional Activity Time (in One Week) After Using the mHealth App for Three Months
Tidsramme: week 1, week 12
week 1, week 12
General Quality of Life Questionnaire: SF-12 Physical Component Summary Score
Tidsramme: baseline, 3 months

SF-12 measures the impact of health on the participant's life and is scored from 0-100 where higher scores indicates higher health related quality of life.

baseline, 3 months
General Quality of Life Questionnaire: SF-12 Mental Component Summary Score
Tidsramme: baseline, 3 months

SF-12 measures the impact of health on the participant's life and is scored from 0-100 where higher scores indicates higher health related quality of life.

baseline, 3 months
Patient Health Questionnaire (PHQ-9) Score
Tidsramme: baseline, 3 months

PHQ-9 is a 9-item questionnaire scored on a 4 point likert scale from 0-3 for a total possible range of scores from 0-27. Higher scores indicate increased depression.

baseline, 3 months
Change in Atrial Fibrillation Effect on Quality of Life Questionnaire (AFEQT) Score
Tidsramme: baseline, 3 months

AFEQT is a 20-item survey scored on a 7 point likert scale from 1-7 (total possible range of scores is converted to be from 0-100) where higher scores indicate higher effect that atrial fibrillation has on the participant's quality of life.

baseline, 3 months
Atrial Fibrillation Symptom Severity (AFSS) Score
Tidsramme: baseline, 3 months

AFSS is a 7-item survey scored on a likert scale from 0-5 for a total possible range of scores from 0-35 where higher scores indicate greater symptom severity.

baseline, 3 months
Percent Correct on the Atrial Fibrillation Knowledge Assessment Tool (AFKAT)
Tidsramme: baseline, 3 months

AFKAT is a 21-item true / false assessment that measures knowledge about atrial fibrillation. Correct answers are scored with a 1 for a total possible range of scores from 0-21. Higher scores indicate increased knowledge of atrial fibrillation. Reported here is the percent correct.

baseline, 3 months
Life's Essential 8 Score After Using the mHealth App for Three Months
Tidsramme: baseline, 3 months

Life's Essential 8 score (LE8) is a composite score between 0-100 that assesses a participant's adherence to 8 lifestyle recommendations with improve cardiovascular health: diet, physical activity, smoking habits, body mass index, cholesterol, blood glucose, and sleep duration. Higher scores are indicative of higher adherence to healthy lifestyle.

baseline, 3 months
Irregular Heart Rate Notifications (in One Week) After Using the mHealth App for Three Months
Tidsramme: baseline, 3 months
baseline, 3 months

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in ECG-age After Using the mHealth App for Three Months
Tidsramme: baseline, 3 months

Participants will obtain single-lead ECGs at baseline and after three months. The time-voltage data are run through an ECG-AI model for estimating ECG-age. ECG-age is a novel metric developed by investigators at Wake Forest. See reference section for relevant publication describing a similar model. Summary results will be reported as ECG-age in years.

baseline, 3 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Matthew M Kalscheur, MD, UW School of Medicine and Public Health

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

17. oktober 2024

Primær færdiggørelse (Faktiske)

22. juli 2025

Studieafslutning (Faktiske)

22. juli 2025

Datoer for studieregistrering

Først indsendt

22. august 2024

Først indsendt, der opfyldte QC-kriterier

27. august 2024

Først opslået (Faktiske)

28. august 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

25. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

1. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 2024-0954
  • A534225 (Anden identifikator: UW Madison)
  • Protocol Version 8/6/2024 (Anden identifikator: UW Madison)
  • 1UL1TR002373 (U.S. NIH-bevilling/kontrakt)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

This study will comply with the NIH Data Sharing Policy and Policy on the Dissemination of NIH-Funded Clinical Trial Information and the Clinical Trials Registration and Results Information Submission rule. As such, this trial will be registered at ClinicalTrials.gov, and results information from this trial will be submitted to ClinicalTrials.gov. Every attempt will be made to publish results in peer-reviewed journals.

IPD-delingstidsramme

Data from this study may be requested from other researchers 7 years after the completion of the primary endpoint by contacting the PI.

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP
  • ICF

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ja

produkt fremstillet i og eksporteret fra U.S.A.

Ja

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner